PDParkinson’s diseasesitagliptinrotenone-inducedrotenone-treatedrotenone
… gut microbiome, shifting towards a profile that may counteract PD pathology.Conclusion These findings demonstrated that sitaglipt…
112articles mentioning diseases
157disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: parkinson’s disease ×
parkinson’s disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning parkinson’s disease
112 articles · page 4 of 10Parkinson’s diseasePDDBSdeep brain stimulationCSAIlevodopa–carbidopa intestinal gel
…d therapies (DAT) have significantly improved the management of Parkinson’s disease (PD). They now include deep brain stimulation (DBS), levodopa–c…
Parkinson’s diseasePD
…opulation-based studies suggest an increased risk of suicide in Parkinson’s disease (PD), but findings have been inconsistent and often limited by …
Parkinson’s diseasePD
…When recommending suitable ways for people with Parkinson’s disease (PD) to increase their physical activity, healthcare profession…
Parkinson’s diseasePD
…orders where the risk significantly increases with age, such as Parkinson’s disease (PD). The purpose of this study was to prospectively investigat…
PDParkinson’s diseaseRadboud university medical centerOMON-registryBilateral deep brain stimulation
… Radboud university medical center. A total of 24 patients with PD eligible for bilateral STN-DBS surgery implanted with Boston Sc…
Parkinson’s diseaselevodopaUniversity of Edinburgh
…tle waste to make levodopa, one of the main drugs used to treat Parkinson’s disease. Scientists at the University of Edinburgh genetically engineer…
Effect of deep brain stimulation on patients with Parkinson’s disease with mild cognitive impairment
Parkinson’s diseasePD-MCIPDDPDDeep brain stimulationDBSEmbasePubMedScopus
…Background Cognitive deficits are prevalent in Parkinson’s disease (PD), often progressing to PD dementia (PDD). Deep brain stimul…
Parkinson’s diseasePDDDSL-DOPAlevodopadopaminergic therapy
… syndrome (DDS) is an uncommon but debilitating complication of Parkinson’s disease (PD), characterised by a compulsive overuse of dopaminergic the…
type 2 diabetes mellitusParkinson’s diseasecardiovascular diseasesmusculoskeletal impairmentdementia
…cluding cardiovascular diseases (OR=0.73; 95% CI 0.67 to 0.80), type 2 diabetes mellitus (OR=0.79; 95% CI 0.68 to 0.91), musculoskeletal impairment (OR=…
Parkinson’s diseasePDPD-relatedacetoacetic acid3-hydroxybutyric acid
…Background Weight loss is a substantial non-motor feature of Parkinson’s disease (PD) associated with worse clinical outcomes, but the underlyin…
Parkinson’s diseasePD
…Background Patients with Parkinson’s disease (PD) frequently develop cardiovascular autonomic dysfunctions, …